Carmelo Bernabeu
Biological Research Center, CSIC, Spain
- Publications: N/A
- Citations: N/A
- Keywords: endothelial cells, endoglin, ALK1, TGF-beta, hereditary hemorrhagic telangiectasia (HHT), preeclampsia
Short Bio
- Carmelo Bernabeu is Research Professor at the Spanish National Research Council (CSIC) since 2003. In 1977 he obtained a doctorate in Chemical Sciences (Biochemistry) from the Autonomous University of Madrid, where he was appointed Assistant Professor in the Department of Microbiology (1977-79). In the University of California at Los Angeles (UCLA) he investigated the ribosome structure by immunoelectron microscopy (1980-1981). Then, at Harvard University Medical School in Boston, he worked in the field of Immunology on the major histocompatibility complex (1982-1983). In 1985, he was appointed Tenured Scientist of the CSIC at the Center for Biological Research Margarita Salas in Madrid, where he currently works. He has also been group leader the Spanish Rare Diseases Network Biomedical Research Center (CIBERER; 2006-2016). Carmelo Bernabeu has published more than 2000 articles in international scientific journals, which have accumulated more than 17,000 citations with an h-index=69 (Google Scholar). He is Editor of different international journals in the area of Biomedicine and is a member of the Global Research and Medical Advisory Board of the Hereditary Hemorrhagic Telangiectasia Foundation (Cure HHT, Monkton, MD, US) since 2003. His scientific interest focuses on the study of vascular pathology, and especially on a rare disease known as Hereditary Hemorrhagic Telangiectasia (HHT). His lines of research involve the two main genes responsible for HHT, known as Endoglin (ENG) and ALK1 (ACVRL1), their role as BMP/TGF-β endothelial receptors, and their implication in angiogenesis, vascular remodeling and vascular homeostasis.
